NCT00235651View on ClinicalTrials.gov

Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients

PHASE3TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

April 30, 2006

Conditions
Lung TransplantationLung Diseases
Interventions
DRUG

Amphotericin B

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

Sponsors
All Listed Sponsors
collaborator

Enzon Pharmaceuticals, Inc.

INDUSTRY

lead

University of Pittsburgh

OTHER